April 29, 2015 3:23 pm
Takeda Oncology is recruiting myeloma patients to participate in a phase III, randomized, double-blind, multicenter clinical trial of ixazomib in combination with lenalidomide (Revlimid®) and dexamethasone. Eligible patients for this trial are newly...
April 29, 2015 3:06 pm
In his blog, “How to Be Safer as You Live Longer,” IMF Chairman Brian Durie, MD cited the value of annual PET/CT as a screening tool to monitor low-level myeloma, detect hidden infection or an early second cancer. But what should a patient know when...
April 29, 2015 3:02 pm
Bristol-Myers Squibb (BMS) has opened an expanded access protocol for its monoclonal antibody elotuzumab in combination with Revlimid® and dexamethasone. Expanded access is a process regulated by the Food and Drug Administration (FDA) that allows...
April 1, 2015 3:14 pm
Order a Free Pillow Talk Care Package that includes a pillow-decorating project as well as materials that will help begin those often-difficult conversations.